Skip to main content
Leo Kim, MD, Ophthalmology, Boston, MA

LeoAmKimMD

Ophthalmology Boston, MA

Retinal Disease

Associate Professor, Ophthalmology, Harvard Medical School, Monte J. Wallace Chair in Retina

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

  • Office

    243 Charles St
    # Retina
    Boston, MA 02114
    Phone+1 617-391-5896

Summary

  • Dr. Leo Kim is an ophthalmologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts Eye and Ear, MelroseWakefield Healthcare, Mount Auburn Hospital, Massachusetts General Hospital, and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 12 years. He specializes in retinal disease and is experienced in retina surgery and vitreoretinal disease.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2006 - 2009
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 2005 - 2006
  • Yale School of Medicine
    Yale School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - Present
  • MA State Medical License
    MA State Medical License 2011 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

Journal Articles

  • Retinal Imaging Findings in Carriers with PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms  
    Grayson W Armstrong, Leo A Kim, Itika Garg, Megan Kasetty, JAMA Ophthalmology

Press Mentions

  • Preclinical Tests Show mRNA-Based Treatments Effective for Blinding Condition
    Preclinical Tests Show mRNA-Based Treatments Effective for Blinding ConditionDecember 3rd, 2024
  • Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
    Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsMarch 22nd, 2020
  • Researchers Identify Genetic Mutation Tied to Alzheimer’s Disease Protection
    Researchers Identify Genetic Mutation Tied to Alzheimer’s Disease ProtectionNovember 4th, 2019
  • Join now to see all

Professional Memberships